Abstract
The Epstein-Barr virus (EBV) is a B lymphotropic virus that infects the majority of the human population. All EBV strains transform B lymphocytes, but some strains, such as M81, also induce spontaneous virus replication. EBV encodes 22 microRNAs (miRNAs) that form a cluster within the BART region of the virus and have been previously been found to stimulate tumor cell growth. Here we describe their functions in B cells infected by M81. We found that the BART miRNAs are downregulated in replicating cells, and that exposure of B cells in vitro or in vivo in humanized mice to a BART miRNA knockout virus resulted in an increased proportion of spontaneously replicating cells, relative to wild type virus. The BART miRNAs subcluster 1, and to a lesser extent subcluster 2, prevented expression of BZLF1, the key protein for initiation of lytic replication. Thus, multiple BART miRNAs cooperate to repress lytic replication. The BART miRNAs also downregulated pro- and anti-apoptotic mediators such as caspase 3 and LMP1, and their deletion did not sensitize B-cells to apoptosis. To the contrary, the majority of humanized mice infected with the BART miRNA knockout mutant developed tumors more rapidly, probably due to enhanced LMP1 expression, although deletion of the BART miRNAs did not modify the virus transforming abilities in vitro. This ability to slow cell growth could be confirmed in non-humanized immunocompromized mice. Injection of resting B cells exposed to a virus that lacks the BART miRNAs resulted in accelerated tumor growth, relative to wild type controls. Therefore, we found that the M81 BART miRNAs do not enhance B-cell tumorigenesis but rather repress it. The repressive effects of the BART miRNAs on potentially pathogenic viral functions in infected B cells are likely to facilitate long-term persistence of the virus in the infected host.
Highlights
The Epstein-Barr virus (EBV) is a strongly B lymphotropic virus that infects the majority of the world human population and is associated with the development of malignant tumors, mainly lymphomas and carcinomas of the nasopharynx (NPC) and of the stomach [1]
We addressed the role played by the BART microRNAs, a subgroup of the EBV microRNAs, by generating a virus that lacks them and by comparing the characteristics of this modified virus with those of the unmodified virus
We found that the BART microRNAs cooperate to curb EBV multiplication, both in infected cells and in humanized mice
Summary
The Epstein-Barr virus (EBV) is a strongly B lymphotropic virus that infects the majority of the world human population and is associated with the development of malignant tumors, mainly lymphomas and carcinomas of the nasopharynx (NPC) and of the stomach [1]. Infected cells express a set of latent proteins ascribed to subfamilies known as Epstein-Barr virus nuclear antigens (EBNA) and latent membrane proteins (LMP), most of which are essential or strongly potentiate the B cell transformation process [1]. EBV encodes 44 miRNAs that are divided into two clusters located around the BHRF1 gene (BHRF1 miRNAs) or within the introns of the BART gene (BART miRNAs) [3,4,5]. A recombinant virus that lacks this cluster retains only 1/ 20th of the wild type transforming capacity [8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.